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Abstract The signal transducer and activator of tran-
scription 3 (STAT3) contributes to cardioprotection by
ischemic pre- and postconditioning. Mitochondria are cen-
tral elements of cardioprotective signaling, most likely by
delaying mitochondrial permeability transition pore
(MPTP) opening, and STAT3 has recently been identiﬁed in
mitochondria. We now characterized the mitochondrial
localization of STAT3 and its impact on respiration and
MPTP opening. STAT3 was mainly present in the matrix of
subsarcolemmal and interﬁbrillar cardiomyocyte mito-
chondria. STAT1, but not STAT5 was also detected in
mitochondria under physiological conditions. ADP-stimu-
lated respiration was reduced in mitochondria from mice
with a cardiomyocyte-speciﬁc deletion of STAT3 (STAT3-
KO) versus wildtypes and in rat mitochondria treated with
the STAT3 inhibitor Stattic (STAT3 inhibitory compound,
6-Nitrobenzo[b]thiophene 1,1-dioxide). Mitochondria from
STAT3-KO mice and Stattic-treated rat mitochondria tol-
erated less calcium until MPTP opening occurred. STAT3
co-immunoprecipitated with cyclophilin D, the target of the
cardioprotective agent and MPTP inhibitor cyclosporine A
(CsA). However, CsA reduced infarct size to a similar
extent in wildtype and STAT3-KO mice in vivo. Thus,
STAT3 possibly contributes to cardioprotection by stimu-
lation of respiration and inhibition of MPTP opening.
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Introduction
Signal transducer and activator of transcription (STAT)
proteins transduce stress signals from the plasma mem-
brane to the nucleus, thereby acting as signaling molecules
and transcriptional regulators [4]. Several STAT proteins
are expressed in the heart, among them are STAT1, 3, and
5. Even though STAT proteins are highly homologous,
their functions differ substantially, notably in ischemia/
reperfusion: STAT1 enhances whereas STAT3 and STAT5
reduce cardiomyocyte death [4, 23].
STAT3 and 5 are involved in the reduction of myocar-
dial injury by ischemic pre- and postconditioning [10, 24,
39, 43], i.e. endogenous cardioprotective phenomena which
have been identiﬁed in all species so far, including man
[17, 28, 42]. Deletion of STAT3 (STAT3-KO) or STAT5
abolishes the infarct size reduction by ischemic precondi-
tioning in mice hearts [41, 46]; the infarct size reduction by
ischemic postconditioning is also attenuated in STAT3-KO
mice [2, 22].
Since the cardioprotection by classical ischemic pre- and
postconditioning is not dependent on increased mRNA
levels [26, 38], it is unlikely that STATs exert their pro-
tective effect via regulation of target gene transcrip-
tion [14], although increased nuclear translocation and
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with ischemic preconditioning [45, 46].
Mitochondria are centrally involved in the signal
transduction of ischemic pre- and postconditioning [18].
Opening of the mitochondrial permeability transition pore
(MPTP) is a major determinant of cardiomyocyte death and
inhibition of MPTP opening is central to protection by
ischemic pre- and postconditioning [8, 15, 21], most likely
also in humans [32]. Recently, STAT3 was identiﬁed in
mouse cardiomyocyte mitochondria, where it regulates
complex I activity and oxygen consumption [44]. The
present study conﬁrms these ﬁndings and extends them to
further address (1) the presence of STATs in subsarco-
lemmal (SSM) and interﬁbrillar (IFM) mitochondria [7, 29,
35]; (2) the interaction of STAT3 with mitochondrial res-
piration and MPTP opening; (3) the interaction of STAT3
with other proteins; and ﬁnally (4) the importance of
STAT3 for cardioprotective strategies.
Materials and methods
The present study was performed with approval by the
Bioethical Committee of the State of Nordrhein-Westfalen,
Germany. It conforms to the Guide for the Care and Use
of Laboratory Animals published by the US National
Institutes of Health (NIH publication No. 85-23, revised
1996).
In the present study, female mice with a cardiomyocyte-
restricted deletion of STAT3 (STAT3-KO), which were
generated by breeding STAT3-ﬂoxed mice (STAT3
ﬂox/ﬂox)
with a-myosin heavy chain promoter/Cre recombinase
transgenic mice (aMHC-Cre
tg/-)[ 20] and their wild type
(WT) littermates, male and female young (8 weeks, 9
females, 1 male) and aged (21 months, 9 females, 2 males)
mice (C57/Bl6 background) and 3-month-old Lewis rats
were studied.
Mitochondria isolation
For respiration and calcium handling, subfractionation,
immunoprecipitation, western blot analysis, and confocal
laser scan microscopy, subsarcolemmal mitochondria (SSM)
were isolated, as described previously [3]. In brief, left
ventricular (LV) tissue was minced in isolation buffer (in
mmol/L: sucrose 250; HEPES 10; EGTA 1, pH 7.4). The
LVs were homogenized (Ultra Turrax, 3 steps of *5 s each,
low speed) and then centrifuged at 600g for 10 min. The
supernatant was centrifuged at 10,780g for 10 min. The
resulting sediment was resuspended in isolation buffer and
centrifuged at 7,650g for 10 min. To analyze STAT1 and
STAT3 content in SSM and interﬁbrillar mitochondria
(IFM), SSM and IFM were isolated from rat ventricles, as
previously described [7]. For mitochondrial subfractionation,
immunoprecipitation, and western blot analysis, mitochon-
dria were further puriﬁed by percoll-gradient ultracentrifu-
gation. Mitochondria were layered on top of a 30% percoll
solution in isolation buffer and centrifuged at 35,000g for
30 min. The lower mitochondrial band was collected and
washed twice in isolation buffer by centrifugation at
8,000g for 5 min.
Pharmacological inhibition of STAT3
Rat LV SSM were incubated with 100 lmol/L Stattic
(STAT3 inhibitory compound, 6-Nitrobenzo[b]thiophene
1,1-dioxide), a concentration previously shown to reduce
STAT3 phosphorylation in isolated mouse hearts [11], or
DMSO as vehicle for 1 h at 4C and subsequently analyzed
for STAT3 phosphorylation at tyrosine 705 and serine 727
by immunoprecipitation (percoll-puriﬁed mitochondria).
Non-puriﬁed mitochondria were used to study mitochon-
drial oxygen consumption and calcium-induced MPTP
opening.
Mitochondrial function
The respiration of 0.1 mg/mL SSM proteins was measured
in a Clark-type oxygen electrode (Strathkelvin, Glasgow,
UK) at 25C in incubation buffer using 5 mmol/L gluta-
mate and 2.5 mmol/L malate as substrates for complex 1 or
5 mmol/L succinate (in combination with 2 lmol/L rote-
none to inhibit complex 1) as substrate for complex 2.
After recording of basal oxygen consumption, respiration
was determined after the addition of 40 lmol/L ADP [7].
Complex 4 respiration was determined after the addition of
1.8 lM antimycin A to inhibit complex 3 and 300 lM
TMPD (N,N,N0,N0-tetramethyl-p-phenylenediamine) and
3 mM ascorbate—which donates electrons to cytochrome
oxidase via the reduction of cytochrome c. Maximal res-
piration was determined after the subsequent addition of
1.3 lmol/L oligomycin to inhibit the ATP synthase and
30 nmol/L FCCP.
Calcium retention capacities of 0.1 mg/mL rat SSM or
0.075 mg/mL mouse SSM were measured in 2 ml incu-
bation buffer without EGTA at 25C using 5 mmol/L
glutamate and 2.5 mmol/L malate as substrates for com-
plex 1 or 5 mmol/L succinate with 2 lmol/L rotenone as
substrate for complex 2. Extramitochondrial calcium was
detected using 0.5 lmol/L calcium green 5 N (Invitrogen,
Carlsbad, CA, USA) with a Cary Eclipse spectrophotom-
eter at excitation and emission wavelengths of 500 and
530 nm, respectively. Experiments were performed in the
presence and absence of 40 lmol/L ADP and 1.2 mmol/L
MgCl2. Six nmol (mouse SSM without ADP and MgCl2)
or 10 nmol (all other groups) CaCl2 were added once per
772 Basic Res Cardiol (2010) 105:771–785
123minute until an increase in calcium green ﬂuorescence was
detected, reﬂecting MPTP opening.
Subfractionation of mitochondria
Mitochondria were subfractionated following a modiﬁed
protocol [36]. Freshly isolated percoll-puriﬁed rat LV SSM
were resuspended in 150 mmol/L KCl supplemented with
100 lM digitonin and protease inhibitors (Complete,
Roche, Basel, Switzerland). After incubation for 10 min on
ice, the mitochondria were centrifuged at 10,000g for
10 min at 4C. The supernatant contained the proteins of
the intermembrane space. The sediment was resuspended
in isolation buffer supplemented with 200 lmol/L digito-
nin. An equal volume of sunﬂower oil was added, and the
mitochondria were vigorously mixed for 5 min. After
centrifugation for 5 min at 14,000g, the lower phase
containing the matrix was separated from the interphase
containing the membrane proteins.
Mitochondrial swelling was induced by incubation in
hypoosmoticsolution (5 mmol/Lsucrose,5 mmol/LHepes,
1 mmol/L EGTA, pH 7.2) for 10 min before normalizing
the osmolarity by adding hyperosmotic solution [37].
Immunoprecipitation and western blot analysis
Mitochondria or right ventricles were lysed in 19 Cell lysis
buffer [Cell Signaling, Beverly, MA, USA; containing in
mmol/L: Tris (pH 7.5) 20, NaCl 150, EDTA 1, EGTA 1,
sodium pyrophosphate 2.5, b-glycerolphosphate 1, Na3VO4
1, Triton X-100 1%, Leupeptin 1 lg/mL, supplemented
with 19 Complete Protease Inhibitor Cocktail (Roche,
Basel, Switzerland)], and subsequently centrifuged at
13,000g for 10 min. The protein concentration of the
supernatant was determined using the Dc protein assay
(BioRad, Hercules, CA, USA).
For immunoprecipitation, 400 lg rat mitochondrial
proteins were incubated with antibodies against total or
phosphorylated STAT3 (Tyr705 or Ser727), Tom20, anti-
rabbit or anti-mouse horseradish peroxidase conjugated
IgGs for 1 h at 4C. Protein A Agarose (Santa Cruz) was
added to each sample followed by overnight incubation at
4C. Protein A Agarose beads were washed three times
with 500 ll PBS supplemented with 19 Complete Protease
Inhibitors. After adding sample buffer, the samples were
boiled for 5 min at 95C.
Immunoprecipitated proteins, 5 lg subfractionated
mitochondrial proteins or 25 lg total mitochondrial or
right ventricular proteins were electrophoretically sepa-
rated on 10% SDS gels and transferred to nitrocellulose
membranes. Protein transfer was controlled by staining of
membranes with Ponceau S. After blocking, the mem-
branes were incubated with primary antibodies and then
washed with the respective secondary antibodies. Immu-
noreactivities were detected using the SuperSignal West
Femto Maximum Sensitivity Substrate (Pierce, Rockford,
IL, USA) and densitometrically quantiﬁed with Scion
Image software (Frederick, ML, USA).
Ischemia/reperfusion injury in vivo
Female STAT3-KO mice or their WT littermates were
anesthetized with pentobarbital sodium (80 mg/kg ip). The
temperature of the animals was kept stable between 36.6
and 37.4C using heating pads, and the electrocardiogram
was monitored continuously. After intubation (polyethyl-
ene-60 tubing), the animals were ventilated with a stroke
rate of 130/min and a tidal volume of 1 mL. A midline
thoracotomy and pericardiotomy were performed. The left
anterior descending coronary artery (LAD) was occluded
2–3 mm distal to the tip of the left auricle using a 7.0 silk
suture and a small tube to form a snare for 30 min. 5 min
before reperfusion, 10 mg/kg cyclosporine A or 0.9% NaCl
as vehicle were administered intravenously. Hearts were
then reperfused for 120 min. 1 U/g heparin was given
intraperitoneally 20 min before the end of reperfusion. At
the end of the protocol, the LAD was re-occluded, 1 mL of
5% Evans Blue was injected into the left ventricle (LV),
and mice were killed with a KCl bolus. Hearts were
excised, and atrial and right ventricular tissues were
removed. LV tissue was washed, frozen for 30 min at
-20C, cut into 5–6 transverse slices, and incubated for
20 min at 37C in 2% TTC (2,3,5-triphenyl tetrazolium
chloride) and for 12 h in 10% formalin. Tissue sections
were photographed and infarct size was calculated as per-
cent of the area at risk by planimetry.
Antibodies
The following antibodies were used in the present study:
rabbit polyclonal anti-mouse phosphorylated STAT3
(Tyr705, Cell Signaling, Beverly, MA, USA), rabbit
polyclonal anti-mouse phosphorylated STAT3 (Ser727,
Cell Signaling, Beverly, MA, USA), rabbit polyclonal anti-
mouse total STAT3 (Cell Signaling, Beverly, MA, USA),
mouse monoclonal anti-mouse total STAT3 (Cell Signal-
ing, Beverly, MA, USA), rabbit polyclonal anti-rat total
connexin43 (Invitrogen, Carlsbad, CA, USA), mouse
monoclonal anti-rat sodium/potassium (Na
?/K
?)-ATPase
(Upstate, Waltham, MA, USA), mouse monoclonal anti-
dog sarcoplasmic calcium (SERCA2)-ATPase (Sigma,
Saint Louis, MO, USA), rabbit monoclonal anti-human
histone deacetylase 2 (HDAC2, Abcam, Cambridge, UK),
mouse monoclonal anti-rabbit GAPDH (Hytest, Turku,
Finland), rabbit polyclonal anti-human translocase of the
outer membrane 20 (Tom20, Santa Cruz, Santa Cruz, CA,
Basic Res Cardiol (2010) 105:771–785 773
123USA), rabbit polyclonal anti-human VDAC (voltage-
dependent anion channel, Abcam, Cambridge, UK), mouse
monoclonal anti-human ATP synthase a (BD Transduction,
San Diego, CA, USA), mouse monoclonal anti-rat cyto-
chrome c (Santa Cruz, Santa Cruz, CA, USA), rabbit
polyclonal anti-human cyclophilin D (Acris, Hiddenhau-
sen, Germany), rabbit polyclonal anti-human MnSOD
(manganese superoxide dismutase, Upstate, Lake Placid,
NY, USA), or mouse monoclonal anti-rat cyclophilin D
(MitoSciences, Eugene, OR, USA).
Statistics
Data are presented as mean values ± SEM. Western blot
data of subfractionated mitochondria and infarct size data
were compared by two-way repeated measures ANOVA
and Fisher’s LSD. Western blot data on the expression and
phosphorylation level of STAT1, STAT3, and Tom20 in
SSM/IFM and on STAT3 or Cx43 in young/aged mito-
chondria, as well as data on mitochondrial respiration were
compared by unpaired Student’s t test. A p\0.05 indi-
cated a signiﬁcant difference.
Results
The mitochondrial preparations used to study the presence
of STAT proteins were not contaminated, since western blot
analysis on different amounts (2–30 lg) of rat LV SSM
proteinswasnegativeformarkerproteinsofthesarcolemma
(Na
?/K
?-ATPase), sarcoplasmic reticulum (sarcoplasmic/
endoplasmic reticulum calcium ATPase 2a, Serca2a),
cytosol (glycerolaldehyde-3-phosphate dehydrogenase,
GAPDH), nucleus (histone deacetylase 2, HDAC2), but
positive for the mitochondrial markers voltage-dependent
anion channel (VDAC) and ATP synthase a. In rat LV
mitochondria, both STAT1 and STAT3 were detected,
whereas STAT5 immunoreactivity was absent (Fig. 1a).
TheamountsofSTAT1andSTAT3weresimilarinboth,the
SSM and IFM populations (Fig. 1c, d). In mitochondria
isolated from STAT3-KO mice, STAT3-speciﬁc immuno-
reactivity was largely reduced, whereas STAT1 immuno-
reactivity was preserved (Fig. 1b). The presence of STAT3
in WT mitochondria and the loss of STAT3 immunoreac-
tivity in STAT3-KO mitochondria were conﬁrmed by con-
focal laser scan microscopy (Appendix Fig. 9).
Since only STAT3 and STAT5 have an established role
in endogenous cardioprotection, but only STAT3 is present
in mitochondria, we subsequently focussed our investiga-
tions on mitochondrial STAT3.
Mitochondrial STAT3 was dually phosphorylated at
tyrosine 705 and serine 727, as shown by immunoprecip-
itation and subsequent western blot analysis (Fig. 2b) as
well as by confocal laser scan microscopy (Appendix
Figs. 9 and 10). In STAT3-KO mitochondria, no signal for
STAT3 phosphorylated at Ser727 and for STAT3 phos-
phorylated at Tyr705 was detected (Appendix Fig. 9).
Total STAT3 was immunoprecipitated from rat LV
SSM. The speciﬁcity of the immunoprecipitation was
demonstrated by the lack of STAT3 immunoreactivity in
the control IgG precipitation and lack of manganese
superoxide dismutase (MnSOD) and cytochrome c signals
in the STAT3 precipitation (Fig. 2a). Both serine-phos-
phorylated and total STAT3 co-immunoprecipitated with
the presequence receptor Tom20 (translocase of the outer
membrane 20), which is part of the mitochondrial import
machinery, in rat LV protein extracts (Fig. 2c). Also,
mitochondrial STAT3 co-immunoprecipitated with cyclo-
philin D, which is involved in the regulation of MPTP
opening (Fig. 2d).
The submitochondrial localization of STAT3 was ana-
lyzed by western blot on rat LV SSM subfractionated into
proteins of the intermembrane space, the inner and outer
membrane, and the matrix. The matrix was not contami-
nated with marker proteins of the intermembrane space
(cytochrome c), outer or inner membrane (VDAC or ATP
synthase a, respectively), but was positive for the marker
protein cyclophilin D and for STAT3 (Figs. 3a, b). The
presence of STAT3 in the mitochondrial matrix was con-
ﬁrmed by confocal laser scan microscopy (Appendix
Fig. 11). When mitochondrial swelling was induced by
incubating the mitochondria in hypoosmotic buffer,
immunoreactivities of marker proteins of the mitochondrial
intermembrane space (adenylate kinase 2 (AK2), cyto-
chrome c) were reduced, whereas STAT3 signal intensity
was unchanged (Fig. 3c). These data were conﬁrmed by
confocal laser scan microscopy showing that 80 ± 3% of
control mitochondria (as identiﬁed by MnSOD immuno-
reactivity, matrix marker protein) and 77 ± 4% of swollen
mitochondria were positive for STAT3, whereas the
number of AK2-positive mitochondria was reduced from
38 ± 4% in control mitochondria to 7 ± 1% in swollen
mitochondria (n = 3, p\0.05).
In order to characterize the function of mitochondrial
STAT3, mitochondrial oxygen consumption was measured.
Supporting prior data [44], ADP-stimulated respiration was
reduced in STAT3-KO mitochondria using substrates
for complex 1. However, no signiﬁcant differences
were found when using complex 2 substrates (Fig. 4), and
when measuring complex 4-mediated respiration (in nmol
O2 min
-1 mg
-1protein, STAT3-KO: 385 ± 22, n = 12 vs.
WT: 426 ± 23, n = 12, p = ns), or uncoupled respiration
(STAT3-KO: 362 ± 29, n = 12 vs. WT: 401 ± 30,
n = 12, p = ns).
Incubation of isolated rat SSM with 100 lmol/L of the
STAT3-speciﬁc inhibitor Stattic signiﬁcantly decreased the
774 Basic Res Cardiol (2010) 105:771–785
123phosphorylation of STAT3 at Tyr705 and also tended to
decrease the phosphorylation of STAT3 at Ser727 (Fig. 5a,
b). Neither 100 nor 200 lmol/L of the STAT3-speciﬁc
inhibitor Stattic affected mitochondrial autoﬂuorescence or
membrane potential, indicating that Stattic had no acute
toxic effect on mitochondria (Appendix Fig. 12). Stattic
did not impact on basal respiration using substrates for
complex 1 or 2, but decreased ADP-stimulated respiration
for complex 1 and—to a lesser extent—also for complex 2
(Fig. 5c, d).
Calcium-induced MPTP opening was measured by cal-
cium green 5 N. The calcium concentration which induced
MPTP opening was similar in mitochondria from WT and
STAT3-KO mice under basal conditions (no ADP and
MgCl2) with complex 1 substrates (Fig. 6a). In contrast, in
the presence of ADP and MgCl2, mimicking more closely
the physiological situation, STAT3-KO mitochondria tol-
erated less calcium until MPTP opening occurred (Fig. 6b).
Binding of cyclosporine A (CsA) to cyclophilin D delayed
MPTP opening compared to control conditions, again, in
the presence of ADP and MgCl2. The STAT3 inhibitor
Stattic accelerated calcium-induced MPTP opening in rat
mitochondria incubated with substrates for complex 1 even
in the absence of ADP and MgCl2, and this effect was
enhanced in the presence of ADP (Figs. 6c, d). CsA
delayed MPTP opening to a lesser extent in Stattic-treated
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123than in DMSO-treated mitochondria. In STAT3-KO mito-
chondria, Stattic did not alter calcium-induced MPTP
opening in the absence of ADP (in nmol CaCl2/mg protein,
DMSO: 726.5 ± 16.1; Stattic: 713.5 ± 24.0, n = 6,
p = ns), thereby excluding unspeciﬁc effects of Stattic on
MPTP opening.
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123Using substrates for complex 2, MPTP opening in the
presence of ADP and MgCl2 was induced at similar cal-
cium concentrations in WT and STAT3-KO mitochondria
(in nmol CaCl2/mg protein, WT: 1,164 ± 47, n = 7 vs.
STAT3-KO: 1,264 ± 56, n = 7, p = ns). However, Stattic
treatment of rat mitochondria again accelerated MPTP
opening (in nmol CaCl2/mg protein, DMSO: 1,357 ± 67,
n = 7 vs. Stattic: 629 ± 39, n = 7, p\0.05).
Since STAT3 co-immunoprecipitated with cyclophilin
D and cyclophilin D inhibition with CsA delayed MPTP
more effectively in control than in STAT3-KO or Stattic-
treated mitochondria, we studied the effects of CsA
on ischemia/reperfusion injury in WT and STAT3-KO
hearts in vivo. The area at risk (as percentage of the LV)
was not different between groups (WT ? NaCl:
25.5 ± 1.8%, n = 7; STAT3 KO ? NaCl: 31.1 ± 1.5%,
n = 7; WT ? CsA: 25.4 ± 2.2, n = 10; STAT3
KO ? CsA: 25.6 ± 1.1, n = 7, p = ns). CsA reduced
infarct size after 30 min ischemia and 120 min reperfu-
sion to a similar extent in WT and in STAT3-KO hearts
in vivo (Fig. 7). Comparison with historical data [2]
demonstrated that CsA and ischemic postconditioning
induced infarct size reduction of similar magnitude in
WT mice, whereas the cardioprotection by ischemic
postconditioning, but not by CsA was lost in STAT3-KO
mice.
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STAT3 decreases mitochondrial
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for complex 1 (a) or succinate
with rotenone as substrate for
complex 2 (b)
DMSO Stattic DMSO Stattic
basal ADP-
stimulated
c
0
20
40
60
80
100
120
d
p<0.05
0
10
20
30
40
50
60
70
80 p<0.05
basal ADP-
stimulated
STAT3 Tyr705
STAT3
86 kDa
86 kDa
S
t
a
t
t
i
c
D
M
S
O
a
STAT3 Ser727
STAT3
86 kDa
86 kDa
S
t
a
t
t
i
c
D
M
S
O
b
0
20
40
60
80
100
120
p
h
o
s
p
h
o
r
y
l
a
t
e
d
 
/
 
t
o
t
a
l
 
S
T
A
T
3
 
(
i
n
 
%
 
D
M
S
O
)
DMSO
STAT3 Tyr705
STAT3 Ser727
p<0.05
n
m
o
l
 
O
2
·
m
i
n
-
1
·
m
g
 
p
r
o
t
e
i
n
-
1
n
m
o
l
 
O
2
·
m
i
n
-
1
·
m
g
 
p
r
o
t
e
i
n
-
1
Fig. 5 Pharmacological inhibition of STAT3 decreases mitochon-
drial ADP-stimulated oxygen consumption. a Total STAT3 was
immunoprecipitated from puriﬁed rat LV SSM which were incubated
with 100 lmol/L Stattic or DMSO. Western blot analysis was
performed for STAT3 phosphorylated at tyrosine 705, serine 727 or
total STAT3 (n = 4). The ratio of phosphorylated over total STAT3
in Stattic-treated mitochondria is shown in percentage of DMSO-
treated control mitochondria (b). Oxygen consumption was measured
under basal conditions and after addition of 40 lM ADP to rat LV
SSM incubated for 1 h at 4C with DMSO or 100 lmol/L Stattic
using glutamate/malate as substrates for complex 1 (c, n = 6) or
succinate with rotenone as substrate for complex 2 (d, n = 6)
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123We have reported a decrease of STAT3 in RV total
protein extracts from aged WT mice before [2, 5]. In the
present study, a reduced STAT3 protein level was also seen
in mitochondria isolated from LV tissue of aged mice
(Fig. 8). As positive control served the decreased level of
connexin 43 in aged mitochondria, which we have also
described before [5]. In contrast, the mitochondrial content
of ATP synthase a was not reduced with age.
Discussion
The present study demonstrates the presence of STAT1 and
STAT3, but not of STAT5 in cardiomyocyte mitochondria.
Our data conﬁrm the previously described localization of
STAT3 in cardiomyocyte mitochondria [44] and extend
these prior data in that the mitochondrial localization of
STAT proteins is not restricted to STAT3 but also true for
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123STAT1. The lack of STAT5 in cardiomyocyte mitochon-
dria under basal conditions does not exclude a possible
mitochondrial import of STAT5 following ischemia/
reperfusion; alternatively, the STAT5-mediated cardio-
protection by ischemic preconditioning [46] works inde-
pendently from mitochondrial signal transduction cascades.
In the present study, STAT1 and STAT3 were found in
SSM and IFM, mitochondrial populations which differ in
their protein composition as well as in their respiratory
function and calcium retention capacity [7, 29, 35].
Therefore, the opposing roles of STAT1 and STAT3 in
myocardial ischemia/reperfusion—STAT1 is associated
with enhanced and STAT3 with reduced cardiomyocyte
death after ischemia/reperfusion (for review see [4])—
cannot be attributed to diverging localizations in mito-
chondrial subpopulations under physiological conditions.
However, whether or not the distribution of STAT1 and
STAT3 in mitochondrial subpopulations is changed after
ischemia/reperfusion is currently unknown. The residual
STAT3 immunoreactivity detected by western blot analysis
in mitochondria from STAT3-KO hearts is presumably due
to the presence of mitochondria from endothelial cells or
smooth muscle cells—i.e. other STAT3 expressing cell
types in the heart which are not affected by the cardio-
myocyte-speciﬁc STAT3 knockout, but are included in the
mitochondrial preparation.
STAT3 is encoded in the nucleus and therefore has to be
imported into the mitochondria. Both phosphorylated and
total STAT3 co-immunoprecipitated with the mitochondrial
presequence receptor Tom20, suggesting an import of
STAT3 via a Tom20-dependent pathway.
The transcriptional activity of STAT3 is regulated by
post-translational modiﬁcation, i.e. phosphorylation and
dephosphorylation. Two major phosphorylation sites are
known: phosphorylation at tyrosine 705 via Janus kinases
which induces dimerization and translocation into the
nucleus, and phosphorylation at serine 727 which plays a
role in modulating transcriptional activity [25]. Mitochon-
drial STAT3 was phosphorylated at both tyrosine 705 and
serine 727. The phosphorylation of STAT3 at serine 727
appears to be more pronounced. Our data do not allow to
distinguish whether or not STAT3 is phosphorylated prior
to its import or within the mitochondria. Subfractionated
mitochondria were characterized to identify the submito-
chondrial localization of STAT3, and STAT3 was pre-
dominantly detected in the mitochondrial matrix. However,
the degree of phosphorylation of STAT3 in different
mitochondrial compartments remains unclear. Our data are
in accordance to and extend the data by Wegrzyn et al. [44],
who have previously excluded the presence of STAT3 in
the outer membrane of liver mitochondria. STAT3 as a
transcriptional activator in the mitochondrial matrix may
inﬂuence the transcription of genes encoded in the
chondriome. However, Wegrzyn et al. [44] found no dif-
ferences in the transcript levels of mitochondrially encoded
genes in wildtype and STAT3-deﬁcient pro-B cells. These
results suggest that mitochondrial STAT3 serves a function
different from transcriptional activation. Previous data
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Fig. 8 Mitochondrial STAT3
content is reduced in aged
mouse hearts. Western blot
analysis was performed for
STAT3 on LV SSM from young
(8 weeks) and aged (21 months)
wildtype mice. As positive
control served the reduced
mitochondrial content of
connexin 43 and as negative
control the unchanged protein
content of ATP synthase a
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123propose that the serine 727 phosphorylation is important for
the effect of STAT3 on mitochondrial respiratory complex
1 and 2 activities [27, 44].
In the present study, mitochondria isolated from
STAT3-KO hearts had reduced ADP-stimulated complex 1
respiration compared to mitochondria isolated from WT
hearts, conﬁrming previous results [44]. However, when
measuring complex 2- or complex 4-mediated respiration
and uncoupled respiration, only a trend towards a
decreased ADP-stimulated respiration was detected.
STAT3-deﬁciency was associated with decreased complex
5 activity and reduced ATP contents in H-RasV12-trans-
formed cells [12]; however, the present study did not
characterize complex 5 activity and ATP-production of
isolated cardiomyocyte mitochondria.
The investigation of mitochondria isolated from
STAT3-KO hearts does not allow to distinguish whether
the effects of STAT3 on respiration are caused directly by
mitochondrial STAT3 or indirectly by changing the tran-
scription of nuclear-encoded mitochondrial target genes.
We therefore also studied respiration in rat mitochondria,
which were incubated with the STAT3-speciﬁc inhibitor
Stattic. The concentration of 100 lmol/L Stattic has pre-
viously been shown to effectively reduce the tyrosine
phosphorylation of STAT3 in isolated mouse hearts [11].
In the present study, Stattic also decreased mitochondrial
STAT3 tyrosine 705 and tended to reduce STAT3 serine
727 phosphorylation. In Stattic-treated mitochondria,
ADP-stimulated complex 1 respiration was reduced to
about 50% of control. Using complex 2 substrates, Stattic
reduced ADP-stimulated respiration again to a lesser
extent than with complex 1 substrates. Taken together,
genetic reduction and pharmacological inhibition of
STAT3 did not alter basal respiration, but decreased ADP-
stimulated respiration, notably that of complex 1. Whereas
STAT3 has been demonstrated to be associated with
complex 1 and possibly with complex 2 [44], a recent
study calculated the ratio of complexes 1 and 2 over
STAT3 to be in the order of 10
5 [31], making a direct
protein–protein interaction between STAT3 and com-
plexes 1 and 2 unlikely. However, STAT3 may inﬂuence
respiration indirectly via modulation of the activity of
protein kinases, e.g. by facilitating the docking of kinases
to target proteins [30].
The MPTP, a voltage-dependent, high conductance
mitochondrial membrane channel, opens when exposed to
high concentrations of reactive oxygen species and calcium
at normal intracellular pH. The well-established inhibitory
effects of ADP and MgCl2 on calcium-induced MPTP
opening [9, 34] were conﬁrmed in the present study, since
the amounts of calcium needed to induce MPTP opening
were higher in the presence of ADP and MgCl2. Opening
of the MPTP releases cytochrome c and induces
cardiomyocyte apoptosis and necrosis. Inhibition of MPTP
opening is important for cardiomyocyte survival and the
cardioprotection by ischemic pre- and postconditioning
[8, 15, 19, 21]. Calcium-induced MPTP opening occurred
at lower calcium concentrations in STAT3-KO mitochon-
dria than in WT mitochondria respiring on complex 1 only
in the presence of ADP and MgCl2. The more pronounced
MPTP opening of mitochondria respiring on complex 1
with ADP and MgCl2 compared to basal conditions was
also conﬁrmed in Stattic-treated rat mitochondria. Stattic
enhanced calcium-induced MPTP opening already under
basal conditions in rat mitochondria, but not in mouse
STAT3-KO mitochondria. Such accelerated MPTP open-
ing in STAT3-KO mitochondria, especially in the presence
of ADP and MgCl2, may contribute to the loss of endo-
genous cardioprotection in STAT3-deﬁcient mice. Whether
or not the impact of STAT3 on MPTP opening is due to
changes in the mitochondrial membrane potential is
unknown at present.
The more pronounced effect of Stattic on respiration and
MPTP opening compared to that of STAT3-KO mito-
chondria may be due to the fact that Stattic inhibits all
STAT3-containing mitochondria, whereas in mitochondrial
preparations from mice with a cardiomyocyte-speciﬁc
deletion of STAT3, a certain amount of STAT3 containing
mitochondria from endothelial cells, vascular smooth
muscle cells or invading blood cells is still present.
STAT3 co-immunoprecipitated with cyclophilin D, a
matrix protein which facilitates MPTP opening when
bound to the inner mitochondrial membrane [9]. CsA
prevents binding of cyclophilin D to the inner mitochon-
drial membrane, thereby delays MPTP opening and con-
tributes to infarct size reduction after ischemia/reperfusion
injury in animals [1, 16, 21, 40] and man [32]. In the
present study, CsA delayed calcium-induced MPTP open-
ing in isolated mitochondria; however, this delay was more
pronounced in control mitochondria than in STAT3-KO or
Stattic-treated mitochondria. Whereas these in vitro data
might suggest that infarct size reduction by CsA in vivo
might be more pronounced in WT than in STAT3-KO
mice, the present study demonstrated in fact a similar
infarct size reduction by CsA in both genotypes. The
magnitude of infarct size reduction by CsA was compara-
ble to that achieved by ischemic postconditioning in WT
mice [2]. Therefore, inhibition of cyclophilin D by CsA
appears to be rather downstream of STAT3 in the signaling
cascade of cardioprotection, or STAT3 and CsA interaction
with different domains of cyclophilin D. The reduction of
reperfusion injury by maneuvers such as ischemic post-
conditioning is dependent on STAT3 [2, 22], whereas the
reduction of reperfusion injury by inhibition of the STAT3
co-precipitating protein cyclophilin D is apparently
downstream of STAT3.
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123Limitations
The detection of total and phosphorylated STAT1 and
STAT3 in mitochondria by western blot analysis and con-
focal laser scan microscopy is dependent on the afﬁnities of
the respective antibodies towards their target epitopes.
Therefore, an accurate quantiﬁcation of the amounts of total
mitochondrial STAT1 and STAT3 is not possible without
using puriﬁed proteins as standard. Whereas our immuno-
precipitation and confocal laser scan microscopy data sug-
gest that the phosphorylation of STAT3 is more prominent
at Ser727 than at Tyr705, we cannot quantify the ratio of
serine over tyrosine phosphorylated mitochondrial STAT3.
The STAT3 inhibitor Stattic has been described to block the
phosphorylation of STAT3 at Tyr705, and we conﬁrmed
this result in isolated mitochondria. However, the phos-
phorylation of STAT3 at Ser727 also tended to be decreased
by Stattic. We can therefore not distinguish whether the
decreased APD-stimulated respiration and the enhanced
calcium-induced MPTP opening in Stattic-treated mito-
chondria are due to the inhibition of the STAT3 phos-
phorylation at residue Ser727, Tyr705 or both. One could
speculate that the enhanced calcium-induced MPTP open-
ing in STAT3-deﬁcient mitochondria would be paralleled
by enhanced infarct size in STAT3 KO mice after ischemia/
reperfusion injury in vivo. However, similar infarct sizes
were measured in WT and STAT3 KO mice. In contrast to
the unaltered infarct size with ischemia/reperfusion per se,
endogenous cardioprotection by ischemic pre- and post-
conditioning was abolished in STAT3 KO mice. These
ﬁndings suggest that STAT3 deﬁciency can be compensated
during ischemia/reperfusion, but that these compensatory
mechanisms are not sufﬁcient to mediate endogenous car-
dioprotection by ischemic pre- and postconditioning.
Potential clinical relevance
The reduced mitochondrial STAT3 level in aged hearts
may be important for the loss of cardioprotection in aged
mice [2, 5, 6]. Apart from aging, STAT3 expression is
decreased in rats with diabetes [13] and in patients with
end-stage heart failure [33], pathophysiological conditions
also associated with loss of endogenous cardioprotection.
The targeting of STAT3 to the mitochondria promotes Ras-
dependent oncogenic transformation [12]. However, the
present data also point to beneﬁcial roles of mitochondrial
STAT3 for maintaining mitochondrial function and thereby
enhancing cell survival. Mitochondrial STAT3 possibly
contributes to cardioprotection by augmentation of ADP-
stimulated respiration and inhibition of MPTP opening, but
not through interaction with CsA binding to cyclophilin D.
Our data suggest that patients with reduced contents of
STAT3 would beneﬁt from CsA therapy in acute myo-
cardial infarction.
Taken together, STAT1 and STAT3 are localized in the
matrix of cardiomyocyte mitochondria. Mitochondrial
STAT3 stimulates respiration and inhibits calcium-induced
MPTP opening, thereby potentially contributing to
cardioprotection.
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Appendix 1: Pharmacological inhibition of STAT3
To exclude acute toxic effects of Stattic (STAT3 inhibitory
compund, 6-Nitrobenzo[b]thiophene 1,1-dioxide), mito-
chondrial NAD(P)H autoﬂuorescence and membrane
potential were measured of 0.5 mg/mL rat LV SSM. The
effect of Stattic or DMSO as vehicle, respectively, on the
mitochondrial NAD(P)H autoﬂuorescence (excitation
340 nm, emission 460 nm) or membrane potential
(10 nmol/L of the potentiometric dye rhodamine 123,
excitation 503 nm; emission 535 nm) was measured at
25C in incubation buffer [containing in mmol/L: 125 KCl,
10 Tris/MOPS (3-(N-(morpholino)propanesulfonic acid),
1.2 Pi/Tris, 1.2 MgCl2, 0.02 EGTA, 5 glutamate, 2.5
malate, pH 7.4] in a Cary Eclipse spectrophotometer
(Varian, Mulgrave, Australia). The difference between the
ﬂuorescence intensity 1 min prior and 1 min after the
addition of DMSO, 100 lmol/L Stattic or 200 lmol/L
Stattic, respectively, was quantiﬁed. To induce collapse of
the mitochondrial membrane potential, 100 nmol/L FCCP
was added, and the ﬂuorescence intensity was calculated
1 min after FCCP administration (n = 5).
Appendix 2: Confocal laser scan microscopy
For mitochondrial subfractionation, rat LV mitochondria
were incubated in isolation buffer with 600 lmol/L digi-
tonin for 10 min on ice. Mitochondria were collected by
centrifugation and subsequently incubated with 150 mmol/
L KCl for 10 min on ice. Again, mitochondria were col-
lected by centrifugation and resuspended in phosphate-
buffered saline (PBS). Subfractionation of mitochondria
was performed, as previously described [36].
Puriﬁed rat, mouse WT, or STAT3-KO LV mitochon-
dria (intact or treated with digitonin and KCl) were
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123incubated with anti-STAT3 Tyr705, anti-STAT3 Ser727,
anti-STAT3, anti-ATP synthase a, anti-cytochrome c, or
anti-cyclophilin D antibodies for 1 h at 25C with gentle
agitation and, after washing, with the respective secondary
antibodies. Mitochondria were mounted with Vectashield
and were examined by confocal laser scan microscopy
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Fig. 9 Total and
phosphorylated STAT3 are
present in mouse left ventricular
(LV) mitochondria. a LV
subsarcolemmal mitochondria
(SSM) of WT (n = 6) and
STAT3-KO mice (n = 8) were
stained with antibodies against
STAT3 (green) and the
mitochondrial marker
cyclophilin D (red) and were
analyzed by confocal laser scan
microscopy. Overlay pixels are
shown in yellow. Whereas in
SSM isolated from the LV of
WT mice about 91% (347
mitochondria counted) of the
ATP synthase positive
mitochondria were also positive
for STAT3, only 13% (248
mitochondria counted) of the
SSM had immunoreactivity for
STAT3 in STAT3-KO mice.
b SSM from the LV of WT
(n = 4) and STAT3-KO mice
(n = 4) were stained with
antibodies against STAT3
phosphorylated at Ser727
(green) and the mitochondrial
marker cyclophilin D (red) and
were analyzed by confocal laser
scan microscopy. Overlay pixels
are shown in yellow. c SSM
from the LV of WT (n = 4) and
STAT3-KO mice (n = 4) were
stained with antibodies against
STAT3 phosphorylated at
Tyr705 (green) and the
mitochondrial marker
cyclophilin D (red) and were
analyzed by confocal laser scan
microscopy. Overlay pixels are
shown in yellow
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Fig. 10 Mitochondrial STAT3 is phosphorylated. a Subsarcolemmal
mitochondria (SSM) from the rat LV were stained with antibodies
against STAT3 phosphorylated at Tyr705 or Ser727 (green) and the
mitochondrial marker ATP synthase a (red) and were analyzed by
confocal laser scan microscopy (n = 4). Overlay pixels are shown in
yellow. b STAT3 phosphorylated at Tyr705 or Ser727 was immuno-
precipitated from rat SSM proteins. IgGs were used as negative
control. Western blot analysis on immunoprecipitated proteins was
performed for serine or tyrosine phosphorylated STAT3 (n = 4). To
compare signal intensities for STAT3 phosphorylated at Tyr705 or
Ser727, western blots were exposed to X-ray ﬁlms such that the signal
intensities for phosphorylated STAT3 in total right ventricular (RV)
protein extracts were similar
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b
Fig. 11 STAT3 is present in
the matrix of left ventricular
(LV) subsarcolemmal
mitochondria (SSM). a LV rat
SSM (untreated or treated with
digitonin and KCl in order to
remove proteins from the outer
membrane and the
intermembrane space) were
stained with antibodies against
cytochrome c (intermembrane
space, red) and cyclophilin D
(matrix, green), and were
analyzed by confocal laser scan
microscopy. Overlay pixels are
shown in yellow (n = 3).
b Untreated or digitonin/KCl-
treated SSM were stained with
antibodies against STAT3 (red)
and cyclophilin D (green) and
were analyzed by confocal laser
scan microscopy. Overlay pixels
are shown in yellow (n = 3)
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123(LSM Pascal 5, Zeiss, Jena, Germany) at 6309 magniﬁ-
cation. For negative control, primary antibodies were
omitted. Unless otherwise stated, about 20–30 mitochon-
dria were analyzed from each individual experiment (see
Figs. 9, 10, 11, 12).
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